Azenta Inc (AZTA)
44.92
+3.70
(+8.98%)
USD |
NASDAQ |
Nov 04, 16:00
44.86
-0.06
(-0.13%)
After-Hours: 20:00
Azenta Research and Development Expense (TTM): 34.04M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 34.04M |
| March 31, 2024 | 35.10M |
| December 31, 2023 | 34.91M |
| September 30, 2023 | 33.96M |
| June 30, 2023 | 32.67M |
| March 31, 2023 | 30.22M |
| December 31, 2022 | 28.59M |
| September 30, 2022 | 27.54M |
| June 30, 2022 | 26.50M |
| March 31, 2022 | 25.47M |
| December 31, 2021 | 23.81M |
| September 30, 2021 | 22.41M |
| June 30, 2021 | -10.10M |
| March 31, 2021 | -1.581M |
| December 31, 2020 | 8.505M |
| September 30, 2020 | 17.82M |
| June 30, 2020 | 19.56M |
| March 31, 2020 | 19.79M |
| December 31, 2019 | 18.57M |
| September 30, 2019 | 17.32M |
| June 30, 2019 | 53.62M |
| March 31, 2019 | 51.43M |
| December 31, 2018 | 48.68M |
| September 30, 2018 | 46.94M |
| June 30, 2018 | 40.52M |
| Date | Value |
|---|---|
| March 31, 2018 | 40.44M |
| December 31, 2017 | 40.44M |
| September 30, 2017 | 39.88M |
| June 30, 2017 | 39.18M |
| March 31, 2017 | 40.04M |
| December 31, 2016 | 41.81M |
| September 30, 2016 | 44.24M |
| June 30, 2016 | 52.44M |
| March 31, 2016 | 52.45M |
| December 31, 2015 | 52.02M |
| September 30, 2015 | 52.23M |
| June 30, 2015 | 53.11M |
| March 31, 2015 | 53.77M |
| December 31, 2014 | 53.59M |
| September 30, 2014 | 52.65M |
| June 30, 2014 | 51.12M |
| March 31, 2014 | 49.02M |
| December 31, 2013 | 47.86M |
| September 30, 2013 | 46.82M |
| June 30, 2013 | 42.79M |
| March 31, 2013 | 43.09M |
| December 31, 2012 | 47.31M |
| September 30, 2012 | 47.74M |
| June 30, 2012 | 50.68M |
| March 31, 2012 | 49.01M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
-10.10M
Minimum
Jun 2021
35.10M
Maximum
Mar 2024
22.52M
Average
25.47M
Median
Mar 2022
Research and Development Expense (TTM) Benchmarks
| Bruker Corp | 328.80M |
| Harvard Bioscience Inc | 11.42M |
| Bionano Genomics Inc | 42.10M |
| Akoya Biosciences Inc | 20.68M |
| Singular Genomics Systems Inc | 45.13M |